01194nas a2200301 4500000000100000008004100001260001700042653001000059653001200069653003000081653001100111653002300122653001200145653001000157653000900167653001600176653001800192100001400210700001400224700001800238700001700256245006800273300000900341490000700350050003200357520048900389022001400878 1985 d c1985 Jan-Mar10aAdult10aDapsone10aDrug Therapy, Combination10aHumans10aIsonicotinic Acids10aleprosy10aLiver10aMale10aMiddle Aged10aProthionamide1 aKundu S K1 aHazra S K1 aChaudhury S K1 aChatterjee B00aProthionamide and dapsone therapy in leprosy--a clinical study. a90-60 v57 aInfolep Library - available3 a

Combined therapy with prothionamide and dapsone was instituted in fifteen active untreated lepromatous leprosy cases for a period of 18 months. Clinical improvement was good with attainment of zero morphological index in about 66% cases. Bacteriological improvement was rather unsatisfactory as one case only reached zero level. Side effects were observed in few cases necessitating withdrawal of combined therapy and patients' prothionamide compliance was rather unimpressive.

 a0254-9395